192 related articles for article (PubMed ID: 27567189)
1. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
2. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
3. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
[TBL] [Abstract][Full Text] [Related]
4. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
Gui X; Liu S; Yan Y; Gao Z
World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of Ki67 and p53 expression assists the diagnosis and grading of ulcerative colitis-related dysplasia.
Wong NA; Mayer NJ; MacKell S; Gilmour HM; Harrison DJ
Histopathology; 2000 Aug; 37(2):108-14. PubMed ID: 10931232
[TBL] [Abstract][Full Text] [Related]
7. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
[TBL] [Abstract][Full Text] [Related]
8. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
[TBL] [Abstract][Full Text] [Related]
9. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.
Andersen SN; Rognum TO; Bakka A; Clausen OP
Mol Pathol; 1998 Dec; 51(6):327-32. PubMed ID: 10193513
[TBL] [Abstract][Full Text] [Related]
10. p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus.
Shi XY; Bhagwandeen B; Leong AS
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):447-52. PubMed ID: 18665038
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
Shigaki K; Mitomi H; Fujimori T; Ichikawa K; Tomita S; Imura J; Fujii S; Itabashi M; Kameoka S; Sahara R; Takenoshita S
Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
[TBL] [Abstract][Full Text] [Related]
12. Dysplasia-like epithelial atypia in ischemic bowel disease.
Abraham SC; Taggart MW; Loftus EV; Wu TT
Hum Pathol; 2014 Jul; 45(7):1348-57. PubMed ID: 24946975
[TBL] [Abstract][Full Text] [Related]
13. Goblet cell status in idiopathic ulcerative colitis--implication in surveillance program.
Vaiphei K; Saha M; Sharma BC; Bhasin DK; Singh K
Indian J Pathol Microbiol; 2004 Jan; 47(1):16-21. PubMed ID: 15471116
[TBL] [Abstract][Full Text] [Related]
14. Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers.
Jin Y; Sun A; Noriki S; Imamura Y; Fukuda M
Eur J Histochem; 2007; 51(1):1-10. PubMed ID: 17548263
[TBL] [Abstract][Full Text] [Related]
15. COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia.
Frăţilă OC; Iliaş TI
Rom J Morphol Embryol; 2013; 54(1):143-9. PubMed ID: 23529322
[TBL] [Abstract][Full Text] [Related]
16. P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study.
Walsh SV; Loda M; Torres CM; Antonioli D; Odze RD
Am J Surg Pathol; 1999 Aug; 23(8):963-9. PubMed ID: 10435567
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment of a unique basal pattern of p53 expression in ulcerative-colitis-associated neoplasia using computer-assisted cytometry.
Kobayashi S; Fujimori T; Mitomi H; Tomita S; Ichikawa K; Imura J; Fujii S; Itabashi M; Kameoka S; Igarashi Y
Diagn Pathol; 2014 May; 9():99. PubMed ID: 24886509
[TBL] [Abstract][Full Text] [Related]
18. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement.
Sugimoto S; Naganuma M; Iwao Y; Matsuoka K; Shimoda M; Mikami S; Mizuno S; Nakazato Y; Nanki K; Inoue N; Ogata H; Kanai T
Gastrointest Endosc; 2017 Mar; 85(3):639-646.e2. PubMed ID: 27884517
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]